ID   Pedro
AC   CVCL_A0WX
DR   Wikidata; Q108821099
RX   PubMed=22704137;
RX   PubMed=31816142;
RX   PubMed=34079834;
CC   Omics: Deep exome analysis.
CC   Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia.
CC   Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
RX   PubMed=22704137; DOI=10.1016/j.tvjl.2012.05.003;
RA   Maniscalco L., Iussich S., Morello E., Martano M., Biolatti B.,
RA   Riondato F., Della Salda L., Romanucci M., Malatesta D.,
RA   Bongiovanni L., Tirrito F., Gattino F., Buracco P., De Maria R.;
RT   "PDGFs and PDGFRs in canine osteosarcoma: new targets for innovative
RT   therapeutic strategies in comparative oncology.";
RL   Vet. J. 195:41-47(2013).
//
RX   PubMed=31816142; DOI=10.1111/vco.12562;
RA   Sanchez-Cespedes R., Accornero P., Miretti S., Martignani E.,
RA   Gattino F., Maniscalco L., Gola C., Iussich S., Martano M.,
RA   Morello E., Buracco P., Aresu L., De Maria R.;
RT   "In vitro and in vivo effects of toceranib phosphate on canine
RT   osteosarcoma cell lines and xenograft orthotopic models.";
RL   Vet. Comp. Oncol. 18:117-127(2020).
//
RX   PubMed=34079834; DOI=10.3389/fvets.2021.666838; PMCID=PMC8165228;
RA   Gola C., Giannuzzi D., Rinaldi A., Iussich S., Modesto P., Morello E.,
RA   Buracco P., Aresu L., De Maria R.;
RT   "Genomic and transcriptomic characterization of canine osteosarcoma
RT   cell lines: a valuable resource in translational medicine.";
RL   Front. Vet. Sci. 8:666838.1-666838.11(2021).
//